Patient recruitment remains the single most persistent bottleneck in clinical trials today. Despite advances in trial … Why Patient Recruitment Is the Biggest Problem in Clinical Trials TodayRead more
Patient enrollment
How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development
In 2024, nearly 85 percent of U.S. clinical trials failed to enroll sufficient participants on schedule, … How Poor Clinical Trial Recruitment Is Quietly Killing Drug DevelopmentRead more
